John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 67,958 shares at $128.30 ($8.9M) on 2021-05-13, disclosed to the SEC on 2021-05-17.
Open-market sale of $8.9M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.30 | 3,015 | $387K | 4.4% |
| 2 | $128.30 | 3,015 | $387K | 4.4% |
| 3 | $129.32 | 4,512 | $583K | 6.6% |
| 4 | $129.32 | 4,512 | $583K | 6.6% |
| 5 | $130.34 | 9,121 | $1.2M | 13.4% |
| 6 | $130.34 | 9,121 |
| $1.2M |
| 13.4% |
| 7 | $131.18 | 11,203 | $1.5M | 16.5% |
| 8 | $131.18 | 11,203 | $1.5M | 16.5% |
| 9 | $132.32 | 3,481 | $461K | 5.2% |
| 10 | $132.32 | 3,481 | $461K | 5.2% |
| 11 | $133.56 | 1,624 | $217K | 2.4% |
| 12 | $133.56 | 1,624 | $217K | 2.4% |
| 13 | $134.37 | 1,023 | $137K | 1.5% |
| 14 | $134.37 | 1,023 | $137K | 1.5% |
| Total | $130.78 avg | 67,958 | $8.9M | 100% |
| Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |
| ALNY | SELL | 2020-08-21 | $9.5M | — | Filing → |